November 2014 Monthly Test Update

Published on 11/07/14
Molecular Testing
Test NameTest CodeTest Type
Eye Disorders: Deletion/Duplication PanelMD030CGH array
Autism Spectrum Disorders: Deletion/Duplication PanelMD021CGH array
Comprehensive Cardiovascular: Deletion/Duplication PanelDCAR1CGH array
Ciliopathies: Deletion/Duplication PanelDCIL1CGH array
Congenital Disorders of Glycosylation: Deletion/Duplication PanelDCDG1CGH array
Epilepsy and Seizure Disorders: Deletion/Duplication PanelDEPI1CGH array
Neuromuscular Disorders: Deletion/Duplication PanelDNEU1CGH array
Proportionate Short Stature/Small for Gestational Age: Deletion/Duplication PanelMD010CGH array
X-linked Intellectual Disability: Deletion/Duplication PanelDXLI1CGH array
Hypertrophic Cardiomyopathy: Deletion/Duplication PanelMD091CGH array
Dilated Cardiomyopathy: Deletion/Duplication PanelMD092CGH array
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Deletion/Duplication PanelMD096CGH array
Sudden Cardiac Arrest (SCA): Deletion/Duplication PanelMD097CGH array
Achromatopsia, Cone, and Cone-rod Dystrophy: Deletion/Duplication PanelMD131CGH array
Congenital Stationary Night Blindness: Deletion/Duplication PanelMD133CGH array
Flecked-retina Disorders: Deletion/Duplication PanelMD134CGH array
Albinism: Deletion/Duplication PanelMD135CGH array
Leber Congenital Amaurosis: Deletion/Duplication PanelMD137CGH array
Macular Dystrophy/Degeneration/Stargardt Disease: Deletion/Duplication PanelMD138CGH array
Endocrine Cancer: Deletion/Duplication PanelMD202CGH array
Pheochromocytoma-Paraganglioma: Deletion/Duplication PanelMD203CGH array
Brain, CNS, and PNS Cancer: Deletion/Duplication PanelMD204CGH array
High Risk Colorectal Cancer: Deletion/Duplication PanelMD205CGH array
Renal Cancer: Deletion/Duplication PanelMD206CGH array
Gastrointestinal and Colorectal Cancer: Deletion/Duplication PanelMD209CGH array
Congenital Muscular Dystrophy: Deletion/Duplication PanelMD211CGH array
Limb-Girdle Muscular Dystrophy: Deletion/Duplication PanelMD212CGH array
Retinitis Pigmentosa: Deletion/Duplication PanelMD233CGH array
Optic Atrophy: Deletion/Duplication PanelMD234CGH array
Senior-Loken Syndrome: Deletion/Duplication PanelMD235CGH array
Vitreoretinopathy: Deletion/Duplication PanelMD238CGH array
Retina/Photoreceptor Dystrophy: Deletion/Duplication PanelMD239CGH array
Expanded Neuromuscular Disorders: Deletion/Duplication PanelMD360CGH array
Melanoma: Deletion/Duplication PanelMD401CGH array
Pancreatic Cancer: Deletion/Duplication PanelMD402CGH array
Tuberous Sclerosis: Deletion/Duplication PanelMD430CGH array
Cardiomyopathy: Deletion/Duplication PanelMD520CGH array
Cystic Fibrosis: CFTR Expanded Mutation PanelMM530Next Generation Sequencing
Prenatal L1CAM Deletion/Duplication AnalysisMDPZQCGH array
Prenatal PKHD1 Deletion/Duplication AnalysisMDPZRCGH array
Kabuki Syndrome: KMT2D and KDM6A Deletion/Duplication PanelDKABPCGH array

Recent Test Updates

EGL recently updated the following tests: 
  • BCAHP Congenital Adrenal Hyperplasia: Steroid Profile, Quantitative, Dried Blood Spot - New turnaround time of 7 days
  • MM340 Autism Spectrum Disorders: Complete Tier 1 Panel - New turnaround time of 3 weeks
  • MM300 Hereditary Cancer Syndrome: Sequencing Panel - Removed EPCAM from sequencing panel

Test Requisitions - Things to Remember

Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD9 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.

Prior Authorization Reminder

When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.